These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 2506605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.
    Russell KH, Hagenmeyer-Houser SH, Sanberg PR.
    Psychopharmacology (Berl); 1987; 91(1):45-9. PubMed ID: 2881319
    [Abstract] [Full Text] [Related]

  • 4. Scopolamine disrupts leverpress shock escape learning in rats.
    Mattingly BA.
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1635-8. PubMed ID: 3737632
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic-induced defecation in rats as a model for neuroleptic dysphoria.
    Sachdev P, Loneragan C, Westbrook F.
    Psychiatry Res; 1993 Apr; 47(1):37-45. PubMed ID: 8100080
    [Abstract] [Full Text] [Related]

  • 6. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD, Guido RA.
    Life Sci; 1982 Aug 30; 31(9):909-13. PubMed ID: 7176819
    [Abstract] [Full Text] [Related]

  • 7. Cholinergic mechanisms in a simple test of olfactory learning in the rat.
    Hunter AJ, Murray TK.
    Psychopharmacology (Berl); 1989 Aug 30; 99(2):270-5. PubMed ID: 2508165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M, Pozzi O, Biagetti R, Banfi S, Dorigotti L.
    Psychopharmacology (Berl); 1992 Aug 30; 106(2):175-8. PubMed ID: 1549645
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat.
    Ljungberg T.
    Pharmacol Biochem Behav; 1988 Jan 30; 29(1):205-8. PubMed ID: 3353427
    [Abstract] [Full Text] [Related]

  • 13. Modification of novelty preferences in rats by current and prior treatment with scopolamine and methylscopolamine.
    Horsburgh RJ, Hughes RN.
    Psychopharmacology (Berl); 1981 Jan 30; 73(4):388-90. PubMed ID: 6789363
    [Abstract] [Full Text] [Related]

  • 14. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P, Sarau H, McKenzie G.
    Eur J Pharmacol; 1976 Sep 30; 39(1):117-26. PubMed ID: 986946
    [Abstract] [Full Text] [Related]

  • 15. Scopolamine but not haloperidol disrupts training-induced neuronal activity in cingulate cortex and limbic thalamus during learning in rabbits.
    Henzi V, Kubota Y, Gabriel M.
    Brain Res; 1990 Jun 04; 518(1-2):107-14. PubMed ID: 2390715
    [Abstract] [Full Text] [Related]

  • 16. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE, Chapman MA.
    Pharmacol Biochem Behav; 1991 May 04; 39(1):49-54. PubMed ID: 1924511
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopaminergic and cholinergic influences on morphine self-administration in rats.
    Glick SD, Cox RD.
    Res Commun Chem Pathol Pharmacol; 1975 Sep 04; 12(1):17-24. PubMed ID: 1188183
    [Abstract] [Full Text] [Related]

  • 20. Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia.
    Evenden JL, Lavis L, Iversen SD.
    Psychopharmacology (Berl); 1992 Sep 04; 106(2):179-88. PubMed ID: 1312728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.